Green Cross Holdings Corporation

KSE 005250.KS

Green Cross Holdings Corporation Price to Earnings Ratio (P/E) on January 14, 2025: -11.23

Green Cross Holdings Corporation Price to Earnings Ratio (P/E) is -11.23 on January 14, 2025, a 11.65% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Green Cross Holdings Corporation 52-week high Price to Earnings Ratio (P/E) is -10.23 on July 03, 2024, which is 8.89% above the current Price to Earnings Ratio (P/E).
Green Cross Holdings Corporation 52-week low Price to Earnings Ratio (P/E) is -14.48 on March 25, 2024, which is -28.93% below the current Price to Earnings Ratio (P/E).
Green Cross Holdings Corporation average Price to Earnings Ratio (P/E) for the last 52 weeks is -12.52.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

KSE: 005250.KS

Green Cross Holdings Corporation

CEO	Mr. Il-Sup Huh Ph.D.
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	107, Ihyeon-ro 30beon-gil
Employees	154
Sector	Health Care
Industries Biotechnology Pharmaceuticals Vaccines

Description

Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for hemophilia. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies. Green Cross Holdings was founded in 1967 and is headquartered in Yongin, South Korea.

Key trends

Past 5 years